Paperpal Prime Logo

VIEW : Impact Factor & More

eISSN: 2688-268XpISSN: 2688-3988
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on VIEW

VIEW Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • Inspec Inspec
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 4000
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorProfessional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM)
FrequencyBi-monthly
Publication Start Year2020
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 10
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in VIEW ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in VIEW

Proteomic and metabolic signatures of female reproductive factors and risk of age‐related ocular diseases: A large prospective cohort study
  • 24 Apr 2026
  • VIEW
AI‐assisted automated endpoint interpretation for turbidity‐based digital LAMP using bright‐field microscopy
  • 23 Apr 2026
  • VIEW
Whole‐transcriptome sequencing analyses identified exosomal circular RNAs in the plasma of pancreatic cancer patients as novel blood‐based biomarkers of disease
  • 20 Apr 2026
  • VIEW
Cover Picture: Integrating mass spectrometry and systems biology for the modernization of natural medicines: From deciphering chemical complexity to holistic efficacy assessment (View 2/2026)
  • 1 Apr 2026
  • VIEW
Title not available
  • 1 Apr 2026
  • VIEW
Inside Front Cover: Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment (View 2/2026)
  • 1 Apr 2026
  • VIEW
Proteomic and metabolic signatures of female reproductive factors and risk of age‐related ocular diseases: A large prospective cohort study
  • 24 Apr 2026
  • VIEW
AI‐assisted automated endpoint interpretation for turbidity‐based digital LAMP using bright‐field microscopy
  • 23 Apr 2026
  • VIEW
Whole‐transcriptome sequencing analyses identified exosomal circular RNAs in the plasma of pancreatic cancer patients as novel blood‐based biomarkers of disease
  • 20 Apr 2026
  • VIEW
Cover Picture: Integrating mass spectrometry and systems biology for the modernization of natural medicines: From deciphering chemical complexity to holistic efficacy assessment (View 2/2026)
  • 1 Apr 2026
  • VIEW
Title not available
  • 1 Apr 2026
  • VIEW
Inside Front Cover: Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment (View 2/2026)
  • 1 Apr 2026
  • VIEW

FAQs on VIEW